Elisa Luño Fernández-rekin lankidetzan egindako argitalpenak (7)

2018

  1. Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia

    British Journal of Haematology

2015

  1. Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3

    Hematology, Vol. 20, Núm. 8, pp. 435-441

  2. Trisomy 8, a cytogenetic abnormality in myelodysplastic syndromes, is constitutional or not?

    PLoS ONE, Vol. 10, Núm. 6

2014

  1. The international prognostic scoring system does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis

    Haematologica

2012

  1. Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis

    Haematologica, Vol. 97, Núm. 7, pp. 1036-1041

  2. Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes

    British Journal of Haematology, Vol. 159, Núm. 3, pp. 311-321

2008

  1. Refractory anemia with ringed sideroblasts associated with thrombocytosis: Comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status

    International Journal of Hematology, Vol. 88, Núm. 4, pp. 387-395